Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

7 structures for P17812

Entry ID Method Resolution Chain Position Source
2VO1 X-ray 280 A A/B 1-273 PDB
5U03 EM 610 A A/B/C/D 1-591 PDB
7MGZ EM 280 A F/O/P/Q 1-591 PDB
7MH0 EM 620 A A/B/C/D 1-591 PDB
7MIF EM 310 A C/G/H/I 1-591 PDB
7MIG EM 290 A A/B/C/E 1-591 PDB
AF-P17812-F1 Predicted AlphaFoldDB

265 variants for P17812

Variant ID(s) Position Change Description Diseaes Association Provenance
rs751260098
CA795186
RCV000687089
74 Y>C Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
CA795190
RCV000815116
rs376970699
81 R>H Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001054965
rs1642413763
96 Y>C Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001218307
rs1642483599
124 W>G Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001300372
rs143058120
CA795238
129 A>V Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA21132672
rs372858150
RCV000697727
151 V>M Variant assessed as Somatic; impact. Severe combined immunodeficiency due to CTPS1 deficiency [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs140029453
RCV001816869
RCV000804430
CA795259
158 P>S Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1642600970
RCV001302496
196 P>S Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
CA339903232
RCV000798214
rs1433781145
203 E>Q Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1558142847
RCV000686024
CA339903364
212 D>E Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA339904293
RCV001051263
rs1484961348
264 D>Y Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA795376
rs372743741
RCV000652307
294 R>C Variant assessed as Somatic; 0.0 impact. Severe combined immunodeficiency due to CTPS1 deficiency [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs746188198
CA795378
RCV000652308
297 E>K Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA339905096
rs1553180295
RCV000652309
330 H>N Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA339905159
RCV001343618
rs1570970424
336 Y>F Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV002538162
rs140093917
CA795406
RCV000813430
337 I>V Severe combined immunodeficiency due to CTPS1 deficiency Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs150289603
RCV001223628
CA795409
352 V>M Variant assessed as Somatic; 0.0 impact. Severe combined immunodeficiency due to CTPS1 deficiency [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001341137
rs968928651
CA21144754
353 R>C Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000814556
CA795413
rs149054758
363 S>G Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs139001308
RCV001299786
389 R>P Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs1643025482
RCV001305321
425 D>V Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV000896483
CA795491
rs139322260
426 P>A Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA795492
RCV000793000
rs768930904
427 T>M Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs373379651
RCV001206228
CA795495
432 V>M Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
dbSNP
gnomAD
RCV001053259
rs375485430
CA795509
434 V>I Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs568672601
CA795516
RCV001054007
460 K>R Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA21150023
RCV000823296
CA795518
rs773684585
464 M>I Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ExAC
TOPMed
gnomAD
ClinVar
dbSNP
CA21150877
RCV001235942
rs962110557
466 K>R Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV000815306
rs144358815
CA795539
468 Y>C Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA795542
rs374862639
RCV001201743
RCV002560292
471 A>T Inborn genetic diseases Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA795543
RCV001502337
rs75669611
473 Y>H Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1643098135
RCV001325276
487 V>L Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
rs776186929
RCV000820733
CA795582
550 R>Q Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001313986
rs1643134667
566 T>I Severe combined immunodeficiency due to CTPS1 deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001302682
rs755468825
RCV002539504
CA795619
590 H>R Severe combined immunodeficiency due to CTPS1 deficiency Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000520615
rs1553178485
1 M>I No ClinVar
dbSNP
CA795156
rs772880925
3 Y>N No ClinGen
ExAC
TOPMed
gnomAD
CA339901071
rs1173809494
10 V>G No ClinGen
gnomAD
rs1399420536
CA339901078
11 I>T No ClinGen
TOPMed
gnomAD
rs868098496
CA21129458
13 G>E No ClinGen
Ensembl
rs545128484
CA795159
20 A>T No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 22 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA21129462
rs1020690759
22 S>N No ClinGen
TOPMed
rs756725880
CA21129465
25 T>I No ClinGen
Ensembl
CA339901171
rs1164218562
26 I>L No ClinGen
TOPMed
rs1414469321
CA339901192
29 S>A No ClinGen
TOPMed
CA795160
rs761020732
30 C>W No ClinGen
ExAC
gnomAD
rs1288200124
CA339901220
33 H>R No ClinGen
gnomAD
rs1437591985
CA339901305
45 I>T No ClinGen
TOPMed
rs757447163
CA795163
46 D>G No ClinGen
ExAC
gnomAD
CA795183
rs750649864
63 D>A No ClinGen
ExAC
gnomAD
rs758478895
CA795184
65 G>W No ClinGen
ExAC
rs1449689893
CA339901463
67 V>I No ClinGen
gnomAD
rs766634874
CA795185
70 D>G No ClinGen
ExAC
gnomAD
CA339901525
rs1390666438
76 R>W No ClinGen
gnomAD
rs992854556
CA21130303
80 I>S No ClinGen
Ensembl
rs748131892
CA21130313
81 R>C No ClinGen
ExAC
gnomAD
rs748131892
CA795189
81 R>G No ClinGen
ExAC
gnomAD
CA339901573
rs1570940245
84 K>E No ClinGen
Ensembl
CA795191
rs777081020
84 K>N No ClinGen
ExAC
gnomAD
rs1462856637
CA339901576
84 K>R No ClinGen
TOPMed
rs1305511593
CA339901580
85 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA795192
rs748844510
86 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs774085033
CA795194
89 T>I No ClinGen
ExAC
gnomAD
CA795196
rs769195447
92 K>R No ClinGen
ExAC
gnomAD
rs1558131729
CA339901632
93 I>V No ClinGen
Ensembl
CA795197
rs777269285
94 Y>H No ClinGen
ExAC
gnomAD
rs1251825004
CA339901649
95 Q>R No ClinGen
TOPMed
rs1229612141
CA339901654
96 Y>D No ClinGen
TOPMed
rs765840007
CA795199
102 R>Q No ClinGen
ExAC
gnomAD
CA21130376
rs967797072
102 R>W No ClinGen
TOPMed
gnomAD
rs773103801
CA795201
103 K>N No ClinGen
ExAC
gnomAD
rs751846370
CA795203
109 K>R No ClinGen
ExAC
gnomAD
CA339901760
rs1396887884
111 V>A No ClinGen
gnomAD
rs779871759
CA795232
113 V>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1427323373
CA339901809
117 I>V No ClinGen
gnomAD
rs1175574453
CA339901820
118 T>I No ClinGen
gnomAD
rs1376132109
CA339901822
119 D>H No ClinGen
gnomAD
CA795235
rs200274195
121 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs969931235
CA21131839
125 V>L No ClinGen
TOPMed
rs980051840
CA21131844
126 M>V No ClinGen
TOPMed
rs369068887
CA21131850
127 R>K No ClinGen
ESP
rs770911785
CA339901886
128 Q>* No ClinGen
ExAC
TOPMed
gnomAD
rs770911785
CA795237
128 Q>E No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 132 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1558135973
CA339901921
133 V>A No ClinGen
Ensembl
CA339901954
rs1287745644
138 L>V No ClinGen
TOPMed
CA339901962
rs1219310921
139 E>G No ClinGen
gnomAD
TCGA novel 139 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339901973
rs1300096532
141 Q>E No ClinGen
gnomAD
rs76891977
CA21131865
142 V>E No ClinGen
Ensembl
rs1230245306
CA339901981
142 V>L No ClinGen
gnomAD
CA795242
rs760367234
145 I>T No ClinGen
ExAC
gnomAD
CA339902034
rs1244998862
148 G>D No ClinGen
TOPMed
TCGA novel 150 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA21132697
rs111493048
162 A>V No ClinGen
Ensembl
rs5030799
CA21132709
167 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA339902181
rs1223926993
169 K>T No ClinGen
TOPMed
rs1375055654
CA339902222
174 N>K No ClinGen
TOPMed
TCGA novel 179 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339902262
rs1380415309
180 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA339903010
rs1332011741
186 P>A No ClinGen
TOPMed
rs1388344246
CA339903083
192 Q>P No ClinGen
TOPMed
rs757606681
CA795301
196 P>R No ClinGen
ExAC
gnomAD
CA795302
rs765659493
202 R>Q No ClinGen
ExAC
gnomAD
CA339903301
rs1334012902
208 G>R No ClinGen
gnomAD
rs1275601402
CA339903336
210 S>F No ClinGen
gnomAD
TCGA novel 214 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA795324
rs755074273
218 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA795325
rs781197940
220 N>D No ClinGen
ExAC
gnomAD
TCGA novel 222 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1558143827
CA339903647
224 T>A No ClinGen
Ensembl
rs1459946330
CA339903805
237 E>D No ClinGen
gnomAD
CA339903812
rs1322740434
238 P>H No ClinGen
gnomAD
CA795327
rs756348375
239 E>Q No ClinGen
ExAC
gnomAD
rs910605244
CA21140754
248 S>L No ClinGen
TOPMed
rs1237832391
CA339904197
249 S>A No ClinGen
gnomAD
rs763285768
CA795338
252 R>Q No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 253 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 259 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs960838266
CA21140787
260 Q>* No ClinGen
Ensembl
CA795340
rs752105512
262 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA21140820
rs988651280
263 V>I No ClinGen
TOPMed
CA339904318
rs1558150070
267 L>F No ClinGen
Ensembl
rs757565749
CA795341
268 R>* No ClinGen
ExAC
gnomAD
CA21140824
rs757565749
268 R>G No ClinGen
ExAC
gnomAD
CA21140836
rs376715076
268 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
rs768084498
CA795342
270 L>F No ClinGen
ExAC
gnomAD
rs1558150106
CA339904336
271 D>N No ClinGen
Ensembl
rs752776964
CA795343
273 P>R No ClinGen
ExAC
CA522452205
rs1558150141
274 I>* No ClinGen
Ensembl
rs756293454
CA795344
274 I>T No ClinGen
ExAC
gnomAD
CA21140861
rs913948751
274 I>V No ClinGen
TOPMed
gnomAD
CA795345
rs778118708
276 R>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 281 M>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754169230
CA795347
281 M>T No ClinGen
ExAC
gnomAD
CA339904412
rs1570960862
282 L>V No ClinGen
Ensembl
CA795348
rs757068153
283 M>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 289 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339904707
rs1334392362
293 D>G No ClinGen
gnomAD
rs772950670
CA795377
294 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA21142000
rs946377579
298 T>I No ClinGen
TOPMed
rs201674363
CA795379
300 S>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
CA21142013
rs902429844
301 I>V No ClinGen
TOPMed
gnomAD
rs1280869081
CA339904927
308 T>M No ClinGen
TOPMed
TCGA novel 317 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761980609
CA795384
317 V>I No ClinGen
ExAC
gnomAD
CA339905019
rs1213131324
318 I>V No ClinGen
gnomAD
TCGA novel 322 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1216840778
CA339905053
323 H>D No ClinGen
gnomAD
CA339905071
rs1485440787
325 A>V No ClinGen
gnomAD
CA795388
rs568966876
328 I>V No ClinGen
1000Genomes
ExAC
gnomAD
rs878916397
CA21142088
329 N>T No ClinGen
Ensembl
CA339905107
rs1273058626
331 K>T No ClinGen
gnomAD
CA21142096
rs897158288
332 L>M No ClinGen
TOPMed
gnomAD
CA795389
rs751363108
333 E>V No ClinGen
ExAC
gnomAD
CA339905136
rs1344018905
335 K>R No ClinGen
gnomAD
rs955932050
CA339905185
340 A>E No ClinGen
TOPMed
gnomAD
rs955932050
CA21144659
340 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs988433826
CA21144664
347 S>L No ClinGen
TOPMed
gnomAD
TCGA novel 348 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763171719
CA795407
348 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 349 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339905252
rs1181901878
350 E>V No ClinGen
gnomAD
rs759359795
CA795410
353 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA339905288
rs1176322200
356 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs752729298
CA795412
359 Q>H No ClinGen
ExAC
gnomAD
CA21144780
rs933464624
360 K>R No ClinGen
TOPMed
rs759304872
CA795430
365 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1411078565
CA339905357
365 H>R No ClinGen
gnomAD
CA21145720
rs1035045929
367 V>M No ClinGen
Ensembl
rs377341376
CA795433
376 R>Q No ClinGen
ESP
ExAC
gnomAD
rs1570972393
CA339905493
385 I>V No ClinGen
Ensembl
rs756273124
CA21145755
386 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA795435
rs753346173
388 A>S No ClinGen
ExAC
gnomAD
rs139001308
CA795436
389 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA795439
rs755392632
394 P>S No ClinGen
ExAC
gnomAD
CA339905563
rs1427493907
395 F>S No ClinGen
TOPMed
rs36007898 396 L>F Variant assessed as Somatic; 4.619e-05 impact. [NCI-TCGA] No NCI-TCGA
CA339905591
rs1313438794
398 V>M No ClinGen
gnomAD
rs1308589550
CA339905619
CA339905620
402 M>L No ClinGen
TOPMed
gnomAD
CA339905641
rs1335975256
404 L>F No ClinGen
gnomAD
rs1570974451
CA339905650
406 V>M No ClinGen
Ensembl
rs928104008
CA21146515
412 N>S No ClinGen
TOPMed
gnomAD
rs778320711
CA795465
413 V>M No ClinGen
ExAC
gnomAD
TCGA novel 418 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758454289
CA795489
420 N>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 422 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs139322260
CA339905799
426 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1186087104
CA339905804
427 T>A No ClinGen
TOPMed
CA21149921
rs995628555
434 V>A No ClinGen
Ensembl
CA339905871
rs1361861138
436 M>L No ClinGen
TOPMed
gnomAD
rs1361861138
CA339905873
436 M>V No ClinGen
TOPMed
gnomAD
CA795511
rs755109679
437 P>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 438 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs747923861
CA795513
440 N>H No ClinGen
ExAC
gnomAD
rs879055654
CA21149941
441 P>T No ClinGen
Ensembl
CA21149948
rs373379365
442 G>E No ClinGen
ESP
CA339905918
rs777839795
443 Q>E No ClinGen
ExAC
TOPMed
gnomAD
CA21149960
rs377749147
443 Q>H No ClinGen
ESP
TOPMed
gnomAD
CA795515
rs777839795
443 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA339905929
rs1242533359
444 M>K No ClinGen
gnomAD
CA339905933
rs1487911150
445 G>S No ClinGen
gnomAD
rs776113998
CA21149971
446 G>R No ClinGen
Ensembl
TCGA novel 457 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1180858096
CA339906021
458 Q>P No ClinGen
gnomAD
CA339906029
rs1464852519
459 T>N No ClinGen
gnomAD
rs1402151545
CA339906055
463 V>I No ClinGen
gnomAD
rs969669837
CA21149997
464 M>L No ClinGen
TOPMed
gnomAD
rs770906549
CA795517
464 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA339906059
rs969669837
464 M>V No ClinGen
TOPMed
gnomAD
CA21150873
rs1042011642
465 R>K No ClinGen
TOPMed
gnomAD
rs746596357
CA795540
469 G>E No ClinGen
ExAC
gnomAD
CA795544
rs766769279
473 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA795547
rs767772882
479 R>C No ClinGen
ExAC
gnomAD
TCGA novel 481 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339906228
rs1256913133
485 N>S No ClinGen
gnomAD
rs1315656781
CA339906233
486 P>A No ClinGen
gnomAD
rs374491345
CA795558
487 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA339906279
rs1197308357
492 L>S No ClinGen
gnomAD
CA339906277
rs1421326142
492 L>V No ClinGen
gnomAD
CA339906333
rs1476067397
499 F>C No ClinGen
gnomAD
TCGA novel 502 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA795561
rs771384942
502 Q>R No ClinGen
ExAC
gnomAD
rs1391097831
CA339906437
514 L>V No ClinGen
gnomAD
CA339906447
rs1464410039
515 E>G No ClinGen
gnomAD
rs371598753
CA795574
516 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs754570151
CA795575
517 H>L No ClinGen
ExAC
gnomAD
TCGA novel 517 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 518 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 520 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA21154851
rs376248212
521 V>A No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 521 V>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339906499
rs1456618282
521 V>F No ClinGen
gnomAD
rs1297508246
CA339906508
522 G>V No ClinGen
gnomAD
CA339906506
rs1420186734
522 G>W No ClinGen
gnomAD
CA21154871
rs897972168
533 P>L No ClinGen
gnomAD
rs1194994072
CA339906595
535 K>R No ClinGen
TOPMed
CA339906605
rs1442569944
536 P>L No ClinGen
TOPMed
CA795579
rs779365316
540 Y>H No ClinGen
ExAC
gnomAD
CA339906655
rs1558172680
544 L>P No ClinGen
Ensembl
CA21154895
rs868285884
545 L>M No ClinGen
Ensembl
rs1194740794
CA339906661
546 A>T No ClinGen
TOPMed
CA339906669
rs1253616710
547 S>A No ClinGen
TOPMed
rs772675294
CA795581
547 S>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1253616710
CA339906668
547 S>P No ClinGen
TOPMed
rs552737439
CA21154926
550 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
NCI-TCGA
rs760824348
CA795583
552 S>A No ClinGen
ExAC
TOPMed
gnomAD
rs1558172776
CA339906715
553 H>L No ClinGen
Ensembl
rs1454766195
CA339906743
556 Q>E No ClinGen
TOPMed
CA795586
rs762033803
560 R>S No ClinGen
ExAC
gnomAD
CA795607
rs762727625
565 D>N No ClinGen
ExAC
gnomAD
CA339906927
rs747605849
568 S>R No ClinGen
gnomAD
rs17856308
CA21155543
VAR_027055
571 S>I No ClinGen
UniProt
TOPMed
dbSNP
CA21155536
rs17856308
571 S>N No ClinGen
TOPMed
CA339906997
rs1311011345
575 S>P No ClinGen
gnomAD
CA795611
rs149425488
576 P>R No ClinGen
ESP
ExAC
TOPMed
TCGA novel 581 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA795615
rs753610646
582 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA795616
rs753610646
582 E>Q No ClinGen
ExAC
gnomAD
CA339907095
rs1236096123
584 K>N No ClinGen
gnomAD
CA795617
rs780504017
585 F>L No ClinGen
ExAC
gnomAD
CA795618
rs747353209
588 I>V No ClinGen
ExAC
gnomAD
rs1385399511
CA339907143
589 N>I No ClinGen
gnomAD
CA339907178
rs1372227666
592 D>L No ClinGen
gnomAD

1 associated diseases with P17812

[MIM: 615897]: Immunodeficiency 24 (IMD24)

A life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. Patients have early onset of severe chronic viral infections, mostly caused by herpes viruses, including EBV and varicella zooster virus (VZV), and also suffer from recurrent encapsulated bacterial infections, a spectrum of infections typical of a combined deficiency of adaptive immunity. {ECO:0000269|PubMed:24870241}. Note=The disease is caused by variants affecting the gene represented in this entry. A unique and recessive G to C mutation probably affecting a splice donor site at the junction of intron 17-18 and exon 18 has been identified in all patients. It results in expression of an abnormal transcript lacking exon 18 and a complete loss of the expression of the protein. {ECO:0000269|PubMed:24870241}.

Without disease ID
  • A life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. Patients have early onset of severe chronic viral infections, mostly caused by herpes viruses, including EBV and varicella zooster virus (VZV), and also suffer from recurrent encapsulated bacterial infections, a spectrum of infections typical of a combined deficiency of adaptive immunity. {ECO:0000269|PubMed:24870241}. Note=The disease is caused by variants affecting the gene represented in this entry. A unique and recessive G to C mutation probably affecting a splice donor site at the junction of intron 17-18 and exon 18 has been identified in all patients. It results in expression of an abnormal transcript lacking exon 18 and a complete loss of the expression of the protein. {ECO:0000269|PubMed:24870241}.

3 regional properties for P17812

Type Name Position InterPro Accession
domain CTP synthase, N-terminal 2 - 272 IPR017456
domain Glutamine amidotransferase 311 - 542 IPR017926
domain CTP synthase GATase domain 299 - 544 IPR033828

Functions

Description
EC Number 6.3.4.2 Other carbon--nitrogen ligases
Subcellular Localization
  • Cytoplasm, cytosol
  • Mainly cytosolic but when active detected in long filamentous structures (PubMed:25223282)
  • Co-localizes with TNK2 in the cytosolic filaments (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoophidium A subcellular filamentary structure where CTP synthase is compartmentalized in a range of organisms including bacteria, yeast, fruit fly, rat and human.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
CTP synthase activity Catalysis of the reaction: ATP + UTP + glutamine + H20= ADP + phosphate + CTP + glutamate.
identical protein binding Binding to an identical protein or proteins.

8 GO annotations of biological process

Name Definition
'de novo' CTP biosynthetic process The chemical reactions and pathways resulting in the formation of cytidine 5'-triphosphate (CTP) from simpler components.
B cell proliferation The expansion of a B cell population by cell division. Follows B cell activation.
CTP biosynthetic process The chemical reactions and pathways resulting in the formation of CTP, cytidine 5'-triphosphate.
glutamine metabolic process The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid.
nucleobase-containing compound metabolic process Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.
pyrimidine nucleobase biosynthetic process The chemical reactions and pathways resulting in the formation of pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases.
response to xenobiotic stimulus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.
T cell proliferation The expansion of a T cell population by cell division. Follows T cell activation.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q1RMS2 CTPS2 CTP synthase 2 Bos taurus (Bovine) PR
Q5F3Z1 CTPS2 CTP synthase 2 Gallus gallus (Chicken) PR
Q9NRF8 CTPS2 CTP synthase 2 Homo sapiens (Human) PR
P70303 Ctps2 CTP synthase 2 Mus musculus (Mouse) PR
P70698 Ctps1 CTP synthase 1 Mus musculus (Mouse) PR
Q5U2N0 Ctps2 CTP synthase 2 Rattus norvegicus (Rat) PR
Q6PEI7 ctps1 CTP synthase 1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MKYILVTGGV ISGIGKGIIA SSVGTILKSC GLHVTSIKID PYINIDAGTF SPYEHGEVFV
70 80 90 100 110 120
LDDGGEVDLD LGNYERFLDI RLTKDNNLTT GKIYQYVINK ERKGDYLGKT VQVVPHITDA
130 140 150 160 170 180
IQEWVMRQAL IPVDEDGLEP QVCVIELGGT VGDIESMPFI EAFRQFQFKV KRENFCNIHV
190 200 210 220 230 240
SLVPQPSSTG EQKTKPTQNS VRELRGLGLS PDLVVCRCSN PLDTSVKEKI SMFCHVEPEQ
250 260 270 280 290 300
VICVHDVSSI YRVPLLLEEQ GVVDYFLRRL DLPIERQPRK MLMKWKEMAD RYDRLLETCS
310 320 330 340 350 360
IALVGKYTKF SDSYASVIKA LEHSALAINH KLEIKYIDSA DLEPITSQEE PVRYHEAWQK
370 380 390 400 410 420
LCSAHGVLVP GGFGVRGTEG KIQAIAWARN QKKPFLGVCL GMQLAVVEFS RNVLGWQDAN
430 440 450 460 470 480
STEFDPTTSH PVVVDMPEHN PGQMGGTMRL GKRRTLFQTK NSVMRKLYGD ADYLEERHRH
490 500 510 520 530 540
RFEVNPVWKK CLEEQGLKFV GQDVEGERME IVELEDHPFF VGVQYHPEFL SRPIKPSPPY
550 560 570 580 590
FGLLLASVGR LSHYLQKGCR LSPRDTYSDR SGSSSPDSEI TELKFPSINH D